If youve heard whispers about BPC-157 or TB-500 from a trainer or a podcast, this is the first real regulatory movement on any of it
and thats true - thats one of the reasons we dont love threads for collagen-building, and we generally steer patients towards other procedures
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
further notes that NICE CKS guidance states that treatment of B12 deficiency in people with neurologic involvement should include injections on alternate days until there is no further improvement
B12 injections are beneficial for specific individuals: Those diagnosed with B12 deficiency by a physician
Presented for research literature review only Timoshenko TV et al